XML 50 R35.htm IDEA: XBRL DOCUMENT v3.26.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Fair Values of Purchase Rights Granted Under the ESPP
The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the years ended years ended December 31, 2025 and 2024 are set forth in the table below:
Year Ended December 31,Year Ended December 31,
20252024
Expected term (in years)0.5— 2.00.5— 2.0
Expected volatility101 %— 129 %106 %— 139 %
Risk-free interest rate3.87 %— 4.28 %4.60 %— 4.60 %
Schedule of Stock Option Activity
The following table summarizes the activities for all stock options under the Company’s stock-based compensation plans for the year ended December 31, 2025:
Number of Options OutstandingWeighted-Average Exercise PriceWeighted-Average Remaining Contractual TermAggregate Intrinsic Value(1)
Outstanding as of December 31, 2024(2)8,438 $12.93 3.16 years$152 
Granted— $— 
Exercised(3)(80)$3.53 
Forfeited or expired(4)(400)$11.78 
Outstanding as of December 31, 2025(2)7,958 $13.08 3.20 years$424 
Exercisable as of December 31, 2025(5)7,918 $13.11 3.18 years$412 
Vested and expected to vest as of December 31, 2025(6)7,958 $13.08 3.20 years$424 
(1)The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.
(2)Includes 3,530 and 3,620 performance condition stock options as of December 31, 2025 and 2024, respectively.
(3)Includes 4 performance condition stock options.
(4)Includes 86 performance condition stock options.
(5)Includes 3,530 performance condition stock options.
(6)Includes 3,530 performance condition stock options.
Schedule of Restricted Stock Unit Activity
The following table summarizes the activities for all RSUs under the Company’s stock-based compensation plans for the year ended December 31, 2025:
Number of SharesWeighted-Average Grant Date Fair Value Per Share
Outstanding as of December 31, 2024(1)1,902 $4.94 
Granted(2)1,758 $3.26 
Vested(772)$4.84 
Forfeited(3)(572)$4.97 
Outstanding as of December 31, 2025(1)2,316 $3.69 
(1)Includes 323 and 248 performance condition RSUs as of December 31, 2025 and 2024, respectively.
(2)Includes 323 performance condition RSUs.
(3)Includes 248 performance condition RSUs.
Schedule of Stock-Based Compensation Expense
The following table provides information about stock-based compensation expense by award type:
Year Ended
December 31,
2025		December 31,
2024
Stock options$1,475 $2,091 
Restricted stock units3,651 5,043 
Employee stock purchase plan1,560 993 
Total stock-based compensation expense$6,686 $8,127 
The following table provides information about stock-based compensation expense by financial statement line item:
Year Ended
December 31,
2025		December 31,
2024
Cost of revenue (exclusive of depreciation and amortization)$— $— 
Sales and marketing1,069 1,047 
Research and development1,170 1,480 
General and administrative4,447 5,600 
Total stock-based compensation expense$6,686 $8,127